Antigenic profiles of individual-matched pairs of primary and melanoma metastases

Human Pathology

Volumn 40, Issue 10, 2009, Pages 1399-1407

  Meije, Clifton B ^a   Swart, Guido W M ^b   LePoole, Caroline ^c   Das, Pranab K ^a   Van den Oord, Joost J ^d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Antigenic profile; Melanoma metastases pairs; Primary melanoma

Indexed keywords

DIFFERENTIATION ANTIGEN; GLYCOPROTEIN GP 100; GLYCOPROTEIN GP 75; HLA DR ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 2; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TYROSINASE RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOMA CELL; MELANOMA METASTASIS; METASTASIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ADULT; AGED; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 69949116844     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.11.018     Document Type: Article

References (28)

1. Blessing K., Sanders D.S., and Grant J.J. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 32 (1998) 139-146
2. Argenyi Z.B., Cain C., Bromley C., et al. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study. Am J Dermatopathol 16 (1994) 233-240
3. Ben Izhak O., Stark P., Levy R., Bergman R., and Lichtig C. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases. Am J Dermatopathol 16 (1994) 241-246
4. Carrel S., Schreyer M., and Giuffre L. Melanoma associated differentiation antigens: investigation with monoclonal antibodies. Prog Clin Biol Res 256 (1988) 585-595
5. Carrel S., Dore J.F., Ruiter D.J., et al. The EORTC Melanoma Group exchange program: evaluation of a multicenter monoclonal antibody study. Int J Cancer 48 (1991) 836-847
6. van Muijen G.N., Cornelissen L.M., Jansen C.F., et al. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis 9 (1991) 259-272
7. de Vries J.E., Keizer G.D., te Velde A.A., et al. Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells. Int J Cancer 38 (1986) 465-473
8. Le Poole I.C., van den Wijngaard R.M., Verkruisen R.P., et al. Foetal human melanocytes: in situ detection, in vitro culture and differentiation characteristics at 6-11 weeks EGA. Pigment Cell Res 9 (1996) 126-133
9. Vennegoor C., Hageman P., Van Nouhuijs H., et al. A monoclonal antibody specific for cells of the melanocyte lineage. Am J Pathol 130 (1988) 179-192
10. Holzmann B., Brocker E.B., Lehmann J.M., et al. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int J Cancer 39 (1987) 466-471
11. Magro C.M., Crowson A.N., and Mihm M.C. Unusual variants of malignant melanoma. Mod Pathol 19 Suppl 2 (2006) S41-S70
12. Busam K.J. The use and application of special techniques in assessing melanocytic tumours. Pathology 36 (2004) 462-469
13. de Wit N.J., van Muijen G.N., and Ruiter D.J. Immunohistochemistry in melanocytic proliferative lesions. Histopathology 44 (2004) 517-541
14. Orchard G.E. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J 32 (2000) 475-481
15. Isabel Z.Y., and Fitzpatrick J.E. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma. J Cutan Pathol 33 (2006) 33-37
16. Jungbluth A.A., Busam K.J., Gerald W.L., et al. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 22 (1998) 595-602
17. Busam K.J., and Jungbluth A.A. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 6 (1999) 12-18
18. Ruiter D.J., and Brocker E.B. Immunohistochemistry in the evaluation of melanocytic tumors. Semin Diagn Pathol 10 (1993) 76-91
19. Meije C.B., Mooi W.J., Le Poole I.C., van Muijen G.N., and Das P.K. Micro-anatomy related antigen expression in melanocytic lesions. J Pathol 190 (2000) 572-578
20. Thomson T.M., Real F.X., Murakami S., Cordon-Cardo C., Old L.J., and Houghton A.N. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J Invest Dermatol 90 (1988) 459-466
21. Tomita Y., Shibahara S., Takeda A., Okinaga S., Matsunaga J., and Tagami H. The monoclonal antibodies TMH-1 and TMH-2 specifically bind to a protein encoded at the murine b-locus, not to the authentic tyrosinase encoded at the c-locus. J Invest Dermatol 96 (1991) 500-504
22. Le Poole I.C., van den Wijngaard R.M., Westerhof W., Dutrieux R.P., and Das P.K. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 100 (1993) 816-822
23. de Vries T.J., Smeets M., de Graaf R., et al. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group. J Pathol 193 (2001) 13-20
24. Kageshita T., Kuriya N., Ono T., et al. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis. Cancer Res. 53 (1993) 2830-2833
25. Vergilis I.J., Szarek M., Ferrone S., and Reynolds S.R. Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma. J Invest Dermatol 125 (2005) 526-531
26. Haass N.K., and Herlyn M. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 10 (2005) 153-163
27. Meije C.B., Hakvoort T.B., Swart G.W., Westerhof W., Lamers W.H., and Das P.K. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation. J Pathol 196 (2002) 51-58
28. Meije C.B., Das P.K., Jans M.M., et al. Multiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation. J Pathol 197 (2002) 668-676